PMID- 29755479 OWN - NLM STAT- MEDLINE DCOM- 20190624 LR - 20190624 IS - 1664-3224 (Print) IS - 1664-3224 (Electronic) IS - 1664-3224 (Linking) VI - 9 DP - 2018 TI - Lysophosphatidylcholine Promotes Phagosome Maturation and Regulates Inflammatory Mediator Production Through the Protein Kinase A-Phosphatidylinositol 3 Kinase-p38 Mitogen-Activated Protein Kinase Signaling Pathway During Mycobacterium tuberculosis Infection in Mouse Macrophages. PG - 920 LID - 10.3389/fimmu.2018.00920 [doi] LID - 920 AB - Tuberculosis is caused by the infectious agent Mycobacterium tuberculosis (Mtb). Mtb has various survival strategies, including blockade of phagosome maturation and inhibition of antigen presentation. Lysophosphatidylcholine (LPC) is a major phospholipid component of oxidized low-density lipoprotein and is involved in various cellular responses, such as activation of second messengers and bactericidal activity in neutrophils. In this study, macrophages were infected with a low infectious dose of Mtb and treated with LPC to investigate the bactericidal activity of LPC against Mtb. In macrophages infected with Mtb strain, H37Ra or H37Rv, LPC suppressed bacterial growth; however, this effect was suppressed in bone marrow-derived macrophages (BMDMs) isolated from G2A (a G protein-coupled receptor involved in some LPC actions) knockout mice. LPC also promoted phagosome maturation via phosphatidylinositol 3 kinase (PI3K)-p38 mitogen-activated protein kinase (MAPK)-mediated reactive oxygen species production and intracellular Ca(2+) release during Mtb infection. In addition, LPC induced increased levels of intracellular cyclic adenosine monophosphate (cAMP) and phosphorylated glycogen synthase kinase 3 beta (GSK3beta) in Mtb-infected macrophages. Protein kinase A (PKA)-induced phosphorylation of GSK3beta suppressed activation of NF-kappaB in LPC-treated macrophages during Mtb infection, leading to decreased secretion of pro-inflammatory cytokines and increased secretion of anti-inflammatory cytokines. These results suggest that LPC can effectively control Mtb growth by promoting phagosome maturation via cAMP-induced activation of the PKA-PI3K-p38 MAPK pathway. Moreover, LPC can regulate excessive production of pro-inflammatory cytokines associated with bacterial infection of macrophages. FAU - Lee, Hyo-Ji AU - Lee HJ AD - Department of Biological Sciences, Kangwon National University, Chuncheon, South Korea. AD - Institute of Life Sciences, Kangwon National University, Chuncheon, South Korea. FAU - Ko, Hyun-Jeong AU - Ko HJ AD - College of Pharmacy, Kangwon National University, Chuncheon, South Korea. FAU - Song, Dong-Kun AU - Song DK AD - Department of Pharmacology, College of Medicine, Hallym University, Chuncheon, South Korea. FAU - Jung, Yu-Jin AU - Jung YJ AD - Department of Biological Sciences, Kangwon National University, Chuncheon, South Korea. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20180427 PL - Switzerland TA - Front Immunol JT - Frontiers in immunology JID - 101560960 RN - 0 (Cytokines) RN - 0 (Lysophosphatidylcholines) RN - 0 (Reactive Oxygen Species) RN - EC 2.7.1.137 (Phosphatidylinositol 3-Kinase) RN - EC 2.7.11.11 (Cyclic AMP-Dependent Protein Kinases) RN - EC 2.7.11.24 (p38 Mitogen-Activated Protein Kinases) RN - SY7Q814VUP (Calcium) SB - IM MH - Animals MH - Calcium/metabolism MH - Cyclic AMP-Dependent Protein Kinases/immunology/*metabolism MH - Cytokines/immunology MH - Cytoplasm/metabolism MH - Lysophosphatidylcholines/*pharmacology MH - Macrophages/drug effects/*microbiology MH - Male MH - Mice MH - Mice, Inbred C57BL MH - Mycobacterium tuberculosis MH - Phagosomes/drug effects/*physiology MH - Phosphatidylinositol 3-Kinase/*metabolism MH - Phosphorylation MH - RAW 264.7 Cells MH - Reactive Oxygen Species/metabolism MH - *Signal Transduction MH - p38 Mitogen-Activated Protein Kinases/*metabolism PMC - PMC5934435 OTO - NOTNLM OT - Mycobacterium tuberculosis OT - inflammation OT - lysophosphatidylcholine OT - macrophage OT - phagosome maturation EDAT- 2018/05/15 06:00 MHDA- 2018/05/15 06:01 PMCR- 2018/01/01 CRDT- 2018/05/15 06:00 PHST- 2018/01/09 00:00 [received] PHST- 2018/04/13 00:00 [accepted] PHST- 2018/05/15 06:00 [entrez] PHST- 2018/05/15 06:00 [pubmed] PHST- 2018/05/15 06:01 [medline] PHST- 2018/01/01 00:00 [pmc-release] AID - 10.3389/fimmu.2018.00920 [doi] PST - epublish SO - Front Immunol. 2018 Apr 27;9:920. doi: 10.3389/fimmu.2018.00920. eCollection 2018.